Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted treatment for ALS.

Columnist Kristin Neva sometimes get overwhelmed by her increasing caregiver responsibilities, but it helps her to know she's not alone.

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS ...

Mitochondrial genome mutations may be linked to ALS, per a study, opening the door for new ways to diagnosing and treating ...

This November, I AM ALS, a nonprofit dedicated to helping people — both patients and family members — affected by amyotrophic ...

The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...

Columnist Kristin Neva and her husband with ALS are sometimes asked about the way they went about building their accessible home.